Sitemap > Clinical Trials > Oncology
Displaying 1 - 50 of 3673 results
- Bevacizumab and Abraxane as Second-Line Therapy in Triple Negative Metastatic Breast Cancer
- INNO-206 in Patients With Small Cell Lung Cancer
- Phase I Oral mTOR Inhibitor RAD001 in Combination With Capecitabine for Metastatic Breast Cancer
- Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib
- Study of Abiraterone Acetate in Patients With Prostate Cancer
- A Study of Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
- Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan
- Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
- Phase I Study of Abiraterone Acetate in Hormone Refractory Prostate Cancer
- A Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
- A Phase II Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Failed Taxane-Based Chemotherapy
- Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension
- Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer.
- Bortezomib (Velcade) and Rituximab-HyperCVAD in Patients With Mantle Cell Lymphoma
- ABI-008 Trial in Patients With Hormone-Refractory Prostate Cancer
- A Phase II Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer
- Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Sorafenib With TACE to Treat Hepatocellular Carcinoma
- Sunitinib in Treating Patients With Recurrent or Metastatic Endometrial Cancer
- Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)
- A Study of Picoplatin in Colorectal Cancer
- Bortezomib in Combination With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
- Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer
- Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas in First Line of Treatment for the Metastatic Disease
- Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma
- Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)
- A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer
- Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer
- Study of NGR-hTNF as Single Agent in Patients Affected by Metastatic Small Cell Lung Carcinoma
- Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Solid Tumors
- Oral CEP-701 With Chemotherapy to Patients With Acute Myeloid Leukemia (AML) Expressing FLT-3 Mutations
- A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma
- Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma
- Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Blood Stem Cell Transplant for Stage II or III Multiple Myeloma
- Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
- A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia
- Erlotinib in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
- CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to Treatment
- Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer
- Study of XL880 in Adults With Squamous Cell Cancer of the Head and Neck
- Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
- A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer
- Phase II Anastrozole and ZD6474 in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer
- Phase 2 Study of Panzem NCD in Combination With Fixed-Dose Temozolomide to Patients With Recurrent GBM
- A Phase III Study of Dasatinib vs. Imatinib in Patients With Newly Diagnosed Chronic Phase CML
- Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
- A Phase 1/2a Study of ABT-263 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Nilotinib as First-Line Treatment of Ph+ CML in Early Chronic Phase
- Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
- A Phase II, Single Arm, Prospective Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 Next >